SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-003749
Filing Date
2021-05-25
Accepted
2021-05-25 08:00:57
Documents
14
Period of Report
2021-05-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052521.htm   iXBRL 8-K 14423
2 PRESS RELEASE exh_991.htm EX-99.1 20975
  Complete submission text file 0001171843-21-003749.txt   248063

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3095
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25969
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 35566
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 24600
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_052521_htm.xml XML 3131
Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 21957374
SIC: 2834 Pharmaceutical Preparations